Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Andrews

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Molecular Genetics and Metabolism|August 6, 2014
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeuticsJames M Murray, Anne Marie Thompson, Allison Vitsky, et al.
Regulatory Toxicology and Pharmacology : RTP|November 21, 2020
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studiesTimothy K MacLachlan, Sven Kronenberg, Nikki Marshall, et al.
Plos Pathogens|January 2, 2008
Progression of Plasmodium berghei through Anopheles stephensi is density-dependentRobert E Sinden, Emma J Dawes, Yasmene Alavi, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trialsLaura Andrews, Rikke F Andersen, Daniel Webster, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degenerationTimothy K Maclachlan, Michael Lukason, Margaret Collins, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
Regulatory Toxicology and Pharmacology : RTP|July 21, 2018
Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challengesFrank R Brennan, Laura Andrews, Antonio R Arulanandam, et al.
Regulatory Toxicology and Pharmacology : RTP|January 24, 2021
Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomesMichael Walther, John Woodruff, Fanny Edele, et al.
International Immunology|October 11, 2005
Characterization of human phagocyte-derived chitotriosidase, a component of innate immunityMarco van Eijk, Cindy P A A van Roomen, G Herma Renkema, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Molecular Genetics and Metabolism|August 6, 2014
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeuticsJames M Murray, Anne Marie Thompson, Allison Vitsky, et al.
Regulatory Toxicology and Pharmacology : RTP|November 21, 2020
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studiesTimothy K MacLachlan, Sven Kronenberg, Nikki Marshall, et al.
Plos Pathogens|January 2, 2008
Progression of Plasmodium berghei through Anopheles stephensi is density-dependentRobert E Sinden, Emma J Dawes, Yasmene Alavi, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trialsLaura Andrews, Rikke F Andersen, Daniel Webster, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 2, 2010
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degenerationTimothy K Maclachlan, Michael Lukason, Margaret Collins, et al.
Vaccine|September 10, 2005
Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosisSarah C Gilbert, Vasee S Moorthy, Laura Andrews, et al.
Regulatory Toxicology and Pharmacology : RTP|July 21, 2018
Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challengesFrank R Brennan, Laura Andrews, Antonio R Arulanandam, et al.
Regulatory Toxicology and Pharmacology : RTP|January 24, 2021
Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomesMichael Walther, John Woodruff, Fanny Edele, et al.
International Immunology|October 11, 2005
Characterization of human phagocyte-derived chitotriosidase, a component of innate immunityMarco van Eijk, Cindy P A A van Roomen, G Herma Renkema, et al.
Pageof 8